Literature DB >> 28881908

Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.

S Lam1,2, A R Hart1,2.   

Abstract

Physical activity affects the functioning of the gastrointestinal system through both local and systemic effects and may play an important role in reducing the risk of esophageal adenocarcinoma. This review assesses the biological mechanisms and epidemiological evidence for the relationship between physical activity and the development of esophageal adenocarcinoma and its precursor diseases: gastroesophageal reflux disease (GORD) and Barrett's esophagus. A search of PubMed, Medline, Embase, and CINAHL was conducted from their inceptions to 25th March 2017 for analytical studies that examined associations between recreational and/or occupational levels of physical activity and the risk of GORD, Barrett's esophagus, and esophageal adenocarcinoma. Where appropriate, a meta-analysis of effects was undertaken. Seven studies were included (2 cohort, 5 case control). For GORD, there were three case-control studies with 10 200 cases among 78 034 participants, with a pooled estimated OR of 0.67 (95% CI 0.57-0.78) for high versus low levels of recreational physical activity. In Barrett's esophagus, there was a single case-control study, which reported no association, OR 1.19 (95% CI 0.82-1.73). For esophageal adenocarcinoma, there were three studies (two prospective cohort, one case control) with 666 cases among 910 376 participants. The largest cohort study reported an inverse association for high versus low levels of recreational physical activity, RR 0.68, 95% CI 0.48-0.96. The remaining two studies reported no associations with either occupational or combined recreational and occupational activity. Heterogeneity in the measurement of exposure (recreational, occupational, and both) made a pooled estimate for esophageal adenocarcinoma inappropriate. Although limited, there is some evidence that higher levels of recreational physical activity may reduce the risk of both GORD and esophageal adenocarcinoma, but further large cohort studies examining the type, intensity and duration of activities that may be beneficial are needed.
© The Authors 2017. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Barrett's esophagus; esophageal adenocarcinoma; gastroesophageal reflux (GERD)

Mesh:

Year:  2017        PMID: 28881908     DOI: 10.1093/dote/dox099

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

Review 1.  Physical activity and laryngeal cancer.

Authors:  Riccardo Nocini; Fabian Sanchis-Gomar; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2019-12

2.  A Physically Active Status Affects the Circulating Profile of Cancer-Associated miRNAs.

Authors:  Martina Faraldi; Laura Gerosa; Marta Gomarasca; Veronica Sansoni; Silvia Perego; Ewa Ziemann; Giuseppe Banfi; Giovanni Lombardi
Journal:  Diagnostics (Basel)       Date:  2021-04-30

Review 3.  Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis.

Authors:  Fangfang Xie; Yanli You; Jihan Huang; Chong Guan; Ziji Chen; Min Fang; Fei Yao; Jia Han
Journal:  J Sport Health Sci       Date:  2020-09-30       Impact factor: 7.179

4.  Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK Biobank.

Authors:  Andrew T Kunzmann; Kristian P Mallon; Ruth F Hunter; Chris R Cardwell; Úna C McMenamin; Andrew D Spence; Helen G Coleman
Journal:  United European Gastroenterol J       Date:  2018-06-07       Impact factor: 4.623

5.  Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants.

Authors:  Zhanwei Zhao; Zifang Yin; Chaojun Zhang
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.